Insmed (INSM) Interest Coverage Ratio Growth (1y) (2012 - 2026)
Insmed (INSM) Interest Coverage Ratio Growth (1y) (2012 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
762,369.55 Bn |
762,369.51 Bn |
- |
- |
| 2 |
Belite Bio |
55,096.00 Bn |
55,096.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,755.80 Bn |
17,755.79 Bn |
- |
- |
| 4 |
Legend Biotech |
3,486.00 Bn |
3,485.71 Bn |
242.10 Mn |
-76.51% |
| 5 |
Akari Therapeutics |
1,737.42 Bn |
1,737.41 Bn |
- |
-303.06% |
| 6 |
Evaxion A |
1,551.28 Bn |
1,551.26 Bn |
- |
18.06% |
| 7 |
Psyence Biomedical |
227.32 Bn |
227.31 Bn |
- |
75.42% |
| 8 |
Vertex Pharmaceuticals |
110.84 Bn |
103.59 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.71 Bn |
91.71 Bn |
- |
67.94% |
| 10 |
Insmed |
19.79 Bn |
18.57 Bn |
258.54 Mn |
33.64% |
| Date | Value |
|---|
| Mar 31, 2026 |
33.64% |
| Dec 31, 2025 |
-45.18% |
| Sep 30, 2025 |
-77.14% |
| Jun 30, 2025 |
-8.41% |
| Mar 31, 2025 |
-66.37% |
| Dec 31, 2024 |
-24.65% |
| Sep 30, 2024 |
-39.27% |
| Jun 30, 2024 |
-18.92% |
| Mar 31, 2024 |
6.64% |
| Dec 31, 2023 |
6.88% |
| Sep 30, 2023 |
80.89% |
| Jun 30, 2023 |
56.58% |
| Mar 31, 2023 |
72.87% |
| Dec 31, 2022 |
-5.52% |
| Sep 30, 2022 |
-313.31% |
| Jun 30, 2022 |
-206.52% |
| Mar 31, 2022 |
-146.13% |
| Dec 31, 2021 |
30.76% |
| Sep 30, 2021 |
-17.76% |
| Jun 30, 2021 |
-18.46% |
